Recorded on 06/23/25 TD Cowen's Machine Medicine: AI & Health Care podcast series takes on the cross-sector revolution in artificial intelligence and breaks it down one piece at a time. We highlight some of the biggest misconceptions about how AI is and can be used in different health care settings and aim to contextualize the latest and most significant developments in a field defined by rapid innovation. In this episode, TD Cowen's health care analyst Brendan Smith hosts Jeff Elton, Vice Chairman of ConcertAI, to explore how ConcertAI is rewriting the playbook for designing and enrolling clinical trials using AI and data-driven precision. We discuss how ripe the current process of running clinical trials is for this kind of innovation as well as how recent guidance from the FDA is shifting conversations with customers. We also aim to unpack what the path toward widespread AI integration could look like and where the field may go from here, especially as the push for faster and more precise trials continues to be a top priority for the entire health care sector.
Recorded on 06/23/25
TD Cowen's Machine Medicine: AI & Health Care podcast series takes on the cross-sector revolution in artificial intelligence and breaks it down one piece at a time. We highlight some of the biggest misconceptions about how AI is and can be used in different health care settings and aim to contextualize the latest and most significant developments in a field defined by rapid innovation.
In this episode, TD Cowen's health care analyst Brendan Smith hosts Jeff Elton, Vice Chairman of ConcertAI, to explore how ConcertAI is rewriting the playbook for designing and enrolling clinical trials using AI and data-driven precision. We discuss how ripe the current process of running clinical trials is for this kind of innovation as well as how recent guidance from the FDA is shifting conversations with customers. We also aim to unpack what the path toward widespread AI integration could look like and where the field may go from here, especially as the push for faster and more precise trials continues to be a top priority for the entire health care sector.